Area of research
Molecular Biology · Cell Biology
Research interest
Research interests include Microtubule and mitosis dynamics, Cancer-related Molecular Pathways, Ubiquitin and proteasome pathways, and Genomics and Chromatin Dynamics.
Pellino1-mTOR/S6K1 signaling axis is a key pathogenesis for the development of polycystic kidney disease.
Protective Effect of Brain Derived Neurotrophic Factor-Overexpressing Wharton's Jelly-Derived Mesenchymal Stromal Cells in Severe Intraventricular Hemorrhage in Newborn Rats.
The ubiquitin ligase Pellino1 targets STAT3 to regulate macrophage-mediated inflammation and tumor development.
Soluble receptors in cancer: mechanisms, clinical significance, and therapeutic strategies.
Longitudinal single-cell transcriptional dynamics throughout neurodegeneration in SCA1
Ssu72 phosphatase is essential for thermogenic adaptation by regulating cytosolic translation.
Phosphatase Ssu72 Is Essential for Homeostatic Balance Between CD4<sup>+</sup> T Cell Lineages.
The Pellino1-PKCθ Signaling Axis Is an Essential Target for Improving Antitumor CD8+ T-lymphocyte Function.
Protein phosphatases regulate the liver microenvironment in the development of hepatocellular carcinoma.
Ssu72-HNF4α signaling axis classify the transition from steatohepatitis to hepatocellular carcinoma.
Mammalian Ssu72 phosphatase preferentially considers tissue-specific actively transcribed gene expression by regulating RNA Pol II transcription.
Ssu72 is a T-cell receptor-responsive modifier that is indispensable for regulatory T cells.
Ssu72 phosphatase directly binds to ZAP-70, thereby providing fine-tuning of TCR signaling and preventing spontaneous inflammation.
Dysregulation of cancer genes by recurrent intergenic fusions
Pellino1 regulates reversible ATM activation via NBS1 ubiquitination at DNA double-strand breaks.
De novo phosphorylation of H2AX by WSTF regulates transcription-coupled homologous recombination repair.
Senataxin mutations elicit motor neuron degeneration phenotypes and yield TDP-43 mislocalization in ALS4 mice and human patients